Articles from BIOTECH Patent News (September 1, 2000)

1-56 out of 56 article(s)

Title	Type	Words
Advanced Tissue Sciences obtains United States patent.	Brief Article	33
Advanced Tissue Sciences receives broad bioreactor patent.	Brief Article	468
Affymetrix obtains United States patent.	Brief Article	24
Akkadix acquires exclusive license to Pangene's enhanced homologous recombination technologies for plant science applications.	Brief Article	663
BioInvent obtains United States patent.	Brief Article	42
Boston Biomedica awarded United States patent for extraction of nucleic acids from cells using pressure cycling technology.	Brief Article	733
California Institute of Technology applies for patent.	Brief Article	40
Cellegy Pharmaceuticals granted anogesic patent in Europe.	Brief Article	300
Centocor applies for patent.	Brief Article	39
Children's Hospital of Los Angeles applies for patent.	Brief Article	47
Chiron obtains United States patent.	Brief Article	45
Collateral Therapeutics announces gene discovery research and license agreement with University of Texas for heart muscle regeneration program.	Brief Article	528
Cytochroma issued United States patent for retinoid metabolizing protein.	Brief Article	229
Digene Diagnostics obtains United States patent.	Brief Article	49
Dyax expands antibody discovery capabilities.	Brief Article	419
Eli Lilly applies for patent.	Brief Article	27
Enzon obtains United States patent.	Brief Article	45
Epicentre obtains United States patent.	Brief Article	27
Genentech applies for patent.	Brief Article	43
Genetics Institute obtains United States patent.	Brief Article	56
Gliatech applies for patent.	Brief Article	46
Heska wins partial summary judgment in Synbiotics patent case.	Brief Article	364
Human Genome Sciences applies for patent.	Brief Article	47
ID Biomedical files patent infringement suit against third wave technologies.	Brief Article	409
Important United States patent secures Pharming's position on human alpha-glucosidase.	Brief Article	527
Incyte obtains United States patent.		29
Innogenetics obtains United States patent.	Brief Article	58
Isis obtains United States patent.	Brief Article	98
Martek granted patent on fast method to find protein global fold.	Brief Article	307
Martek obtains United States patent.	Brief Article	61
Maxygen awarded broad patent expanding its leadership position in directed molecular evolution.	Brief Article	325
Medarex and Oxford Glycosciences form alliance to develop human therapeutic antibody products.	Brief Article	601
Merck applies for patent.	Brief Article	41
Millennium obtains United States patent.	Brief Article	54
Nature Technology obtains United States patent.	Brief Article	56
Neose obtains United States patent.	Brief Article	33
Novavax co-invented hepatitis E vaccine technology licensed to SmithKline Beecham.	Brief Article	678
Ostex International and Osteometer Biotech settle patent infringement lawsuit.	Brief Article	93
Oxford Biomedica applies for patent.	Brief Article	35
Oxford Glycosciences and Cambridge Antibody Technology announce strategic alliance in protein microarrays.	Brief Article	717
Pasteur Sanofi obtains United States patent.	Brief Article	45
Phairson Medical obtains United States patent.	Brief Article	48
Protein Design Labs enters into second antibody humanization agreement with Lilly.	Brief Article	227
Regeneration Technologies announces exclusive rights to newly patented human tissue technology.	Brief Article	417
Selective Genetics applies for patent.	Brief Article	32
Shin-Etsu obtains United States patent.	Brief Article	46
Statens Serum Institute applies for patent.	Brief Article	51
Takeda Chemical applies for patent.	Brief Article	33
Transgenomic obtains United States patent.	Brief Article	64
Transkaryotic files complaint seeking declaratory judgment against Genzyme.	Brief Article	370
Transkaryotic Therapies obtains United States patent.	Brief Article	51
Unilever obtains United States patent.	Brief Article	55
University of Texas applies for patent.	Brief Article	40
University of Texas obtains United States patent.	Brief Article	39
University of Wisconsin applies for patent.	Brief Article	38
Valentis and Viragen collaborate to develop pegylated natural alpha interferon to treat hepatitis C.	Brief Article	856